Cognitive Behavioral Therapy App for Cancer Pain
(STAMP+CBT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new app that combines Cognitive Behavioral Therapy (CBT) with tools for tracking pain, mood, opioid use, and side effects in people with advanced cancer. The goal is to help patients manage their symptoms better through personalized advice and education. Ideal participants have advanced cancer, experience chronic pain related to their condition or treatment, and use prescribed opioids for pain management. As an unphased trial, this study offers patients the chance to contribute to innovative research that could enhance symptom management for advanced cancer.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must have an active prescription for at least one opioid medication for cancer pain. You cannot participate if you use transmucosal fentanyl.
What prior data suggests that this app is safe for managing cancer pain?
Research shows that cognitive behavioral therapy (CBT) is generally safe for managing pain. Studies have found that it helps people improve their coping skills and feel more in control of their pain. One study on a digital CBT app found significant benefits for cancer patients, suggesting it can be effective and well-tolerated.
Most people use CBT apps without serious side effects. These apps guide users through exercises to manage stress, mood, and pain, making them less likely to cause physical side effects compared to medications. However, as with all treatments, individual experiences can vary. Patients should always consult their doctor about any new treatment to ensure it is appropriate.12345Why are researchers excited about this trial?
Researchers are excited about the Cognitive Behavioral Therapy (CBT) app for cancer pain because it offers a personalized approach to pain management. Traditional treatments for cancer pain often rely on medications or in-person therapy sessions. However, this app stands out by providing tailored education and daily assessments directly to patients via their smartphones. This innovative delivery method allows for real-time symptom tracking and management, making it accessible and convenient for patients to manage their pain and related symptoms anytime, anywhere.
What evidence suggests that the STAMP+CBT app is effective for managing cancer pain?
Research has shown that cognitive behavioral therapy (CBT) can effectively help manage chronic pain, including pain from cancer. One study found that people using internet-based and mobile-based CBT reduced pain more successfully than those with conditions like arthritis and heart disease. Another study demonstrated that remote CBT for chronic pain works well and can be offered to many people. In this trial, participants will use the STAMP+CBT app, which has proven to be a practical way to provide this treatment. Patients have found it easy to use and helpful. This app offers education and self-management tips based on patient-reported symptoms, which can help manage cancer pain better.26789
Who Is on the Research Team?
Desiree Azizoddin, PsyD
Principal Investigator
Stephenson Cancer Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 with advanced cancer experiencing chronic pain (pain score >4) and using opioids to manage it. They must be undergoing treatment or receiving supportive care, not in remission, hospice, or hospitalized. Excludes those with cognitive impairments affecting participation, non-English speakers, recent surgery patients, and individuals under opioid risk mitigation programs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the STAMP+CBT app to track pain, mood, opioid use, and receive tailored education and self-management advice
Post-intervention
Participants continue to use the app for monitoring and follow-up surveys
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy
Cognitive Behavioral Therapy is already approved in European Union, United States, Canada for the following indications:
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Substance use disorders
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
National Cancer Institute (NCI)
Collaborator